CLINICAL TRIALS PROFILE FOR DOCOSANOL
✉ Email this page to a colleague
All Clinical Trials for docosanol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03977792 ↗ | An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis | Not yet recruiting | Ecogene 21 | Phase 2 | 2020-09-01 | BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis. |
NCT03977792 ↗ | An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis | Not yet recruiting | Laboratoire Boreaderme Inc. | Phase 2 | 2020-09-01 | BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for docosanol
Condition Name
Clinical Trial Progress for docosanol
Clinical Trial Phase
Clinical Trial Sponsors for docosanol
Sponsor Name